<DOC>
	<DOCNO>NCT02516358</DOCNO>
	<brief_summary>To quantify local prevalence diabetes mellitus critically ill patient . To understand whether correlation exist premorbid glycaemic control glycaemic status ICU . A subgroup analysis conduct investigate whether relationship exist Neuron Specific Enolase level glycaemic disorder .</brief_summary>
	<brief_title>Glycaemic Alterations ICU</brief_title>
	<detailed_description>The aim study determine local prevalence critical illness-associated hyperglycaemia ( CIAH ) recognise unrecognised diabetes , well evaluate premorbid glycaemia impact relationship three glycaemic domain mortality . The investigator calculate Time In Range ( TIR , 70-180 mg/dl ) evaluate distribution percentage time range non-diabetics diabetic patient , order understand association TIR survival group patient ( patient diabetes patient without diabetes ) . In view potential adverse effect hyperglycaemia , hypoglycaemia glycaemic variability brain , investigator dose Neuron Specific Enolase critically ill patient . The aim define biochemical correlation exist critically ill dysglycaemia NSE plasma concentration .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>ICU patient expect ICU length stay &gt; 48 hour age &lt; 18 year ICU length stay &lt; 48 hour diabetic ketoacidosis hyperosmolar nonketonic hyperglycaemia syndrome pregnancy hypoglycaemic coma acute acute chronic liver failure , liver transplantation endstage liver disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>